Skip to main content

Table 1 Base Analysis results

From: Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry

 

Step-up

Initial Combination

Mean costs (€)

25,377.01

20,856.56

Mean utility (QALY)

3.501

3.545

ICER

–

−139,000 (Dominating)

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us